A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

Clinical trial NCT05999799 · TERMINATED

Trial details

NCT number: NCT05999799
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2023-11-16
Primary completion: 2025-07-23
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.